Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.8560
+0.1560 (22.29%)
At close: Jul 16, 2025, 4:00 PM
0.8198
-0.0362 (-4.23%)
After-hours: Jul 16, 2025, 5:20 PM EDT
Cue Biopharma Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$3.00
Upside
+250.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $2 | Buy | Reiterates | $2 | +133.64% | Apr 2, 2025 |
| Stifel | Stifel | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +367.29% | Aug 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $2 | Buy | Maintains | $15 → $2 | +133.64% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +250.47% | Jul 26, 2024 |
| Stifel | Stifel | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +834.58% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +1,068.22% | Apr 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +834.58% | Apr 3, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +600.93% | Mar 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +834.58% | Nov 6, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +1,068.22% | Jun 26, 2023 |
| Stifel | Stifel | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +834.58% | Jun 15, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,652.34% | May 15, 2023 |
| Stifel | Stifel | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +834.58% | Mar 22, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +1,068.22% | Mar 22, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +717.76% | Nov 21, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $10 | Buy | Maintains | $26 → $10 | +1,068.22% | Aug 24, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.